Human T cell leukemia virus type 1 (HTLV-1) mainly infects CD4+ T cells and induces
chronic, persistent infection in infected individuals, with some developing adult T cell …

Human T-cell leukemia virus type 1 (HTLV-1), the first reported human oncogenic retrovirus,
is the etiologic agent of highly aggressive, currently incurable diseases such as adult T-cell …

Abstract Background Human T-lymphotropic Virus Type I (HTLV-1) is a retrovirus that
persistently infects 5–10 million individuals worldwide and causes disabling or fatal …

Human T-cell leukemia virus type 1 (HTLV-1) infects mainly CD4+ CCR4+ effector/memory T
cells in vivo. However, it remains unknown whether HTLV-1 preferentially infects these T …

Human T lymphotropic virus type 1 (HTLV-1) causes a range of chronic inflammatory
diseases and an aggressive malignancy of T lymphocytes known as adult T-cell …

Human T-cell leukemia virus type-1 (HTLV-1) causes adult T-cell leukemia/lymphoma (ATL).
HTLV-1 carriers have a lifelong asymptomatic balance between infected cells and host …

Human T-cell lymphotropic virus type 1 (HTLV-1) is the etiologic agent of adult T-cell
leukemia/lymphoma (ATL), a rapidly progressing clonal malignancy of CD4+ T lymphocytes …

Human T lymphotropic virus type 1 (HTLV-1) and HTLV-2 are related but pathogenically
distinct viruses. HTLV-1 mainly causes adult T cell leukemia, while HTLV-2 is not associated …

Adult T-cell leukemia/lymphoma (ATLL) is an aggressive malignancy of CD4+ T
lymphocytes caused by human T lymphotropic virus type-1 (HTLV-1) infection. HTLV-1 was …

Human T-lymphotropic virus type 1 (HTLV-1) is linked to multiple diseases, including the
neuroinflammatory disease HTLV-1–associated myelopathy/tropical spastic paraparesis …